
1. blood. 2011 jan 6;117(1):165-74. doi: 10.1182/blood-2010-01-265272. epub 2010 sep
27.

stat6 signaling pathway activated cytokines il-4 il-13 induces
expression epstein-barr virus-encoded protein lmp-1 absence ebna-2: 
implications type ii ebv latent gene expression hodgkin lymphoma.

kis ll(1), gerasimcik n, salamon d, persson ek, nagy n, klein g, severinson e,
klein e.

author information: 
(1)department microbiology, tumor cell biology, karolinska institutet,
stockholm, sweden. lorand.kis@karolinska.se

in line b-lymphotropic nature epstein-barr virus (ebv), virus 
present several types b-cell lymphomas. ebv expresses different set of
latent genes associated tumors, ebv nuclear antigen 1 (ebna-1) and
latent membrane proteins (lmps; type ii latency) classical hodgkin lymphomas
(hls). previously reported exposure vitro ebv-converted, hl-derived
cell line kmh2-ebv cd40-ligand interleukin-4 (il-4) induced expression
of lmp-1. here, show exposure il-4 il-13 alone induced lmp-1 the
absence ebna-2. induction lmp-1 il-4 il-13 mediated the
signal transducer signal transducer activator transcription 6 (stat6) 
a newly defined high-affinity stat6-binding site lmp-1 promoter. il-4
induced lmp-1 also burkitt lymphoma-derived lines tonsillar b cells
infected ebna-2-deficient ebv strain p3hr-1. furthermore, coculture of
ebv-carrying burkitt lymphoma cells activated cd4(+) cells resulted the
induction lmp-1 absence ebna-2. hodgkin/reed-sternberg cells
are known secrete il-13, constitutively activated stat6, be
closely surrounded cd4(+) cells, mechanisms may involved the
expression lmp-1 ebv-positive chronic hls.

doi: 10.1182/blood-2010-01-265272 
pmid: 20876453  [indexed medline]

